Office of Inspector General, U.S. Department of Health and Human Services

New Bullying Prevention Handbook Developed for Youth Sport Coaches

Retrieved on: 
Wednesday, October 11, 2023

Denver, Colorado, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The U.S. Center for SafeSport (The Center) today released a new Bullying Prevention Handbook .

Key Points: 
  • Denver, Colorado, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The U.S. Center for SafeSport (The Center) today released a new Bullying Prevention Handbook .
  • The handbook, which is tailored to coaches of minor athletes, provides useful tools to create safe and inclusive sporting environments for all athletes.
  • “Using the Center’s bullying prevention handbook, caring and engaged coaches can foster supportive environments to help athletes thrive on and off the field.”
    The handbook’s core themes focus on how to:
    Recognize Bullying Behavior: Coaches can learn how to identify bullying behaviors common in youth sports, which can be physical, verbal, sexual, cyber, and may even rise to the level of criminal conduct.
  • “We are providing coaches proven tools and tactics to create the most enriching sport experience possible for their players.”
    The handbook’s release coincides with National Stop Bullying Day during National Bullying Prevention Month, which is meant to raise awareness and educate the public about bullying and cyberbullying prevention.

eHealth Exchange Unveils Exciting Agenda for 2023 Annual Meeting

Retrieved on: 
Tuesday, October 10, 2023

VIENNA, Va., Oct. 10, 2023 (GLOBE NEWSWIRE) -- eHealth Exchange , one of the nation’s oldest and largest health information networks, is thrilled to announce the agenda for its highly anticipated 2023 Annual Meeting scheduled to take place on November 14th in San Diego, CA.

Key Points: 
  • VIENNA, Va., Oct. 10, 2023 (GLOBE NEWSWIRE) -- eHealth Exchange , one of the nation’s oldest and largest health information networks, is thrilled to announce the agenda for its highly anticipated 2023 Annual Meeting scheduled to take place on November 14th in San Diego, CA.
  • This year’s event promises to be a captivating blend of thought leadership, innovation and collaboration among healthcare and health IT professionals, government partners, and health information exchange stakeholders nationwide.
  • In addition to the engaging keynote and informative sessions, the eHealth Exchange Annual Meeting will provide many networking opportunities for current and potential health information exchange partners:
    Executive Director Jay Nakashima is hosting an informal happy hour the evening before for attendees arriving early.
  • The eHealth Exchange Annual Meeting will be in-person at the Town and Country Resort in San Diego, CA, on November 14, 2023.

FTI Consulting Expands Technology Team in Germany with Addition of Corporate Governance and E-Discovery Leaders

Retrieved on: 
Tuesday, October 10, 2023

He helps clients solve complex data challenges through close collaboration between legal and IT teams and advises on corporate governance and compliance matters across industry sectors, including automotive, banking, healthcare, pharmaceutical and aerospace.

Key Points: 
  • He helps clients solve complex data challenges through close collaboration between legal and IT teams and advises on corporate governance and compliance matters across industry sectors, including automotive, banking, healthcare, pharmaceutical and aerospace.
  • He has deep expertise advising clients on compliance best practices and investigative strategies to respond to complex, high-stakes regulatory inquiries.
  • Prior to joining FTI Technology, Dr. Schmitz served in risk, regulatory, forensics and e-discovery advisory roles within multiple Big Four firms.
  • We welcome their experience and leadership to our growing team in Germany.”

Garfunkel Wild Opens Washington, D.C. Office

Retrieved on: 
Tuesday, October 10, 2023

The D.C. location marks the firm's sixth office in the United States and the second opened in the past two years.

Key Points: 
  • The D.C. location marks the firm's sixth office in the United States and the second opened in the past two years.
  • "Garfunkel Wild's full-service, cutting-edge, value-oriented platform presents enormous opportunities for both my clients and the Firm's clients in this region," said David Morrissy.
  • To be directed to a D.C.-based Garfunkel Wild attorney, call 202-780-3366.
  • Sign up on Garfunkel Wild's website to receive regular legal alerts and updates on upcoming complimentary educational sessions.

Comstock Fuels Confirms Biofuel Yields in Excess of 100 Gallons Per Tonne and Carbon Intensity Scores Below 20

Retrieved on: 
Thursday, October 5, 2023

HBO is a unique, compliant, drop-in biointermediate that is used in the production of Sustainable Aviation Fuel and Renewable Diesel Fuel.

Key Points: 
  • HBO is a unique, compliant, drop-in biointermediate that is used in the production of Sustainable Aviation Fuel and Renewable Diesel Fuel.
  • It has been verified to increase the diversity of hydroprocessed, fat-based feedstock and significantly reduce CI scores beyond what is commercially achievable today.
  • The carbon intensity of fossil fuels is industry-benchmarked at between 80 and 95.
  • They surpass existing cellulosic-derived biofuel production yields and CI performance scores that biofuel and petroleum refineries can achieve today.

PureTech to Present at Two Upcoming Investor Conferences

Retrieved on: 
Tuesday, October 17, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that members of the management team will participate in fireside chats at two upcoming investor conferences.

Key Points: 
  • PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that members of the management team will participate in fireside chats at two upcoming investor conferences.
  • “Recently, we have been increasing our focus on our central nervous system (CNS) programs, including LYT-300 and LYT-310, that originated from our Glyph™ technology platform.
  • If approved, KarXT, invented at PureTech, will be the third therapeutic candidate to be taken from inception at PureTech to FDA regulatory approval.
  • PureTech will not move forward with the contemplated plan of merger with Gelesis and will instead focus on other strategic business initiatives.

Most Public Schools Face Challenges in Hiring Teachers and Other Personnel Entering the 2023-24 Academic Year

Retrieved on: 
Tuesday, October 17, 2023

WASHINGTON, Oct. 17, 2023 /PRNewswire/ -- Eighty-six percent of U.S. K-12 public schools reported challenges hiring teachers for the 2023-24 school year, with 83 percent reporting trouble hiring for non-teacher positions, such as classroom aides, transportation staff, and mental health professionals, according to data released today by the National Center for Education Statistics (NCES), the statistical center of the U.S. Department of Education's Institute of Education Sciences (IES).

Key Points: 
  • The most frequently cited teaching positions with vacancies that needed to be filled were general elementary (cited by 71 percent of public schools) and special education teachers (70 percent).
  • These were also the top two barriers identified in hiring for non-teacher positions, with roughly the same rates reported by public schools.
  • For public schools that report feeling understaffed, 67 percent of schools that have classroom aides report feeling understaffed in this area.
  • Eighty-six percent of public schools reported challenges hiring teachers entering the 2023-24 school year and 83 percent reported hiring challenges for non-teaching staff.

GE HealthCare Signs $44 Million Contract with BARDA to Develop Artificial Intelligence-Augmented Ultrasound Technology to Aid Clinicians in Diagnosing and Treating Traumatic Injury and Enhance National Preparedness for Mass Casualty Incidents

Retrieved on: 
Thursday, October 12, 2023

Trauma is a leading cause of death in the United States1 posing an enormous burden to healthcare systems and society.

Key Points: 
  • Trauma is a leading cause of death in the United States1 posing an enormous burden to healthcare systems and society.
  • Injury detection and triage of trauma patients play key roles in successful patient care and resource management, both in everyday situations and in mass casualty events.
  • Technologies that expedite care, including detection, evaluation, and decision-assist capabilities, potentially increase patients’ chances of survival.
  • “Point-of-care ultrasound is an essential tool in emergency situations to help clinicians quickly get the answers they need when treating patients,” said Roland Rott, President and CEO, Ultrasound, GE HealthCare.

Tomato Tariffs Could Cause American Consumers to Pay 50% More for Fresh Tomatoes

Retrieved on: 
Tuesday, October 10, 2023

Without the 2019 Suspension Agreement in place, NatureSweet , the #1 snacking tomato brand headquartered in Texas, and countless other companies would face tariffs of more than 20 percent on the import of fresh tomatoes into the United States.

Key Points: 
  • Without the 2019 Suspension Agreement in place, NatureSweet , the #1 snacking tomato brand headquartered in Texas, and countless other companies would face tariffs of more than 20 percent on the import of fresh tomatoes into the United States.
  • “Tomatoes imported from Mexico generate economic and social value far beyond their retail price,” says Skip Hulett, Vice President and General Counsel for NatureSweet.
  • The study concludes that:
    Consumers can expect to pay prices for fresh tomatoes that average 50% higher than they do today.
  • This tariff would punish companies like NatureSweet, which are doing the right thing.”
    Importantly, importers of fresh tomatoes from Mexico have played by the rules.

Venatorx Pharmaceuticals Awarded a Third Antibiotic BARDA Contract

Retrieved on: 
Tuesday, October 10, 2023

Venatorx has recently completed multiple Phase 1 clinical studies with ceftibuten-ledaborbactam etzadroxil and will advance directly to global Phase 3 clinical trial testing under this contract.

Key Points: 
  • Venatorx has recently completed multiple Phase 1 clinical studies with ceftibuten-ledaborbactam etzadroxil and will advance directly to global Phase 3 clinical trial testing under this contract.
  • “We thank BARDA, ASPR, and HHS for their dedication to scientific innovation and commitment to this private-public partnership.
  • BARDA and Venatorx will share the costs of all studies needed to bring the drug to market, including a planned pivotal global Phase 3 clinical trial to treat cUTI.
  • Venatorx will lead all regulatory activities necessary to seek FDA approval of ceftibuten-ledaborbactam etzadroxil under the contract.